rDNA_origin: profile and news
Pfizer's Genotropin (Somatropin [rDNA origin] for Injection) ... May 4, 2006
...today that the US Food and Drug Administration (FDA) has approved a supplemental new drug application for Genotropin® (somatropin [rDNA origin] for injection ... - DG News
Tercica Presents Updated Increlex Long-Term Treatment Data at the ... May 11, 2006
...(Nasdaq:TRCA) presented today updated safety and efficacy data from 321 patient-years of treatment with Increlex(TM) (mecasermin (rDNA origin) injection) from ... - Genetic Engineering News,
Lilly to Extend Patient Assistance Programs for Medicare Patients May 10, 2006
A favorable opinion from the OIG would allow Lilly to continue providing Forteo(R) (teriparatide [rDNA origin] injection), a treatment for osteoporosis, and ... - PR Newswire (press release),
Phase III Trial Of Oral Cladribine, A Novel Investigational ... May 5, 2006
Luveris(R) (lutropin alfa), Ovidrel PreFilled Syringe(R)/Ovitrelle(R) (choriogonadotropin alfa injection), Serostim(R) [somatropin (rDNA origin) for injection ... - Medical News Today (press release),
Lilly to extend patient assistance programs for Medicare patients May 11, 2006
A favorable opinion from the OIG would allow Lilly to continue providing Forteo (teriparatide [rDNA origin] injection), a treatment for osteoporosis, and ... - News-Medical.net,
Tercica Reports First Quarter Financial Results; Conference Call ... May 9, 2006
...revenue for the first quarter ended March 31, 2006 was $85,000, reflecting the initial quarter of sales of Increlex(TM) (mecasermin (rDNA origin) injection). ... - Genetic Engineering News,
Tercica Announces Poster Presentation at Pediatric Endocrinology ... May 8, 2006
...that it will be presenting updated safety and efficacy data from 321 patient-years of treatment with Increlex(TM) (mecasermin (rDNA origin) injection) from long ... - Genetic Engineering News,
OutSystems Platform Supports Fast Roll-Out of US Biotech May 9, 2006
The company's first product, Increlex(TM) (mecasermin -rDNA origin- injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the ... - The Open Press (press release)
Lilly Reports Q1 EPS of $.77, or 13% Growth Apr 20, 2006
...of recombinant DNA origin, Lilly) Humalog(R) Mix 50/50(TM) (50% insulin lispro protamine suspension, 50% insulin lispro injection (rDNA origin, Lilly) Humatrope ... - MSN Money
NPS Pharmaceuticals Reports First Quarter 2006 Operating Results May 2, 2006
Recent developments included: * The European Commission approved Preotact(R) (parathyroid hormone [rDNA origin] for injection) for the treatment of ... - MSN Money
Tercica to Present at Baird's 27th Annual Growth Stock Conference ... May 4, 2006
The company's first product, Increlex(TM) (mecasermin (rDNA origin) injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the ... - Genetic Engineering News,
Tercica Announces Two Presentations at the Pediatric Academic ... Apr 20, 2006
...two newly developed assays for use in clinical studies to monitor children who have been treated with Increlex(TM) (mecasermin (rDNA origin) injection) for the ... - Genetic Engineering News,
IPLEX(TM) Demonstrates Significant, Dose-Dependent Increases in ... May 1, 2006
...announced results from a prospective, multicenter clinical trial of rhIGF-I/rhIGFBP-3, or IPLEX(TM) (mecasermin rinfabate [rDNA origin] injection) administered ... - Yahoo! News (press release)
NORD Honors Insmed for Role in Developing Treatments for Rare ... Apr 25, 2006
...for Rare Disorders (NORD) last night at its annual Tribute Banquet for the development of IPLEX(TM) (mecasermin rinfabate (rDNA origin) injection) for the ... - International News Service,
European Commission Issues Marketing Authorization for Preotact ... Apr 26, 2006
...partner Nycomed announced today that the European Commission has granted marketing authorization for Preotact (parathyroid hormone [rDNA origin] for injection ... - DG News
European Commission Issues Marketing Authorization for Preotact(R) ... Apr 26, 2006
...www.nycomed.com) announced today that the European Commission has granted marketing authorization for Preotact (parathyroid hormone [rDNA origin] for injection ... - Yahoo! News (press release)
